Yazar "Oğlak, Süleyman Cemil" için listeleme
-
Altered right portal and umbilical vein doppler parameters in fetal macrosomia resulting from pregestational and gestational diabetic mothers: A prospective case-control study
Sezer, Salim; Oğlak, Süleyman Cemil; Atış Aydın, Alev; Süzen Çaypınar, Sema; Kaya, Başak; Bestel, Melih (Türkiye Klinikleri Yayınevi, 2023)Objective: To evaluate the blood flow of the umbilical vein and right portal vein in macrosomic fetuses of diabetic mothers and investigate the effect of maternal insulin treatment on these blood flows.Material and Methods: ... -
Clinicopathological and survival characteristics of mismatch repair status and PD-1 expression in serous ovarian cancer
Ölmez, Fatma; Oğlak, Süleyman Cemil; Akgöl, Sedat; Ölmez, Ömer Fatih; Bilici, Ahmet; Akbayır, Özgür; Gedik Özköse, Zeynep; Can, Esra; Ünal, Ömer; Acar Şirinoğlu, Hicran (College of Physicians and Surgeons Pakistan, 2023)Objective: To evaluate the clinicopathological characteristics of mismatch repair (MMR) deficiency and its clinical outcomes by performing immunohistochemistry (IHC) for MMR genes in the serous ovarian cancer (SOC) tumour ... -
Fetal left ventricular myocardial performance index measured at 11–14 weeks of gestation in fetuses with an increased nuchal translucency
Sezer, Salim; Oğlak, Süleyman Cemil; Kaya, Başak; Behram, Mustafa; Gedik Özköse, Zeynep; Süzen Çaypınar, Sema; Acar, Züat; Gezdirici, Alper; Bornaun, Helen (Wiley, 2023)Objective: This study aimed to evaluate the effect of an increase in nuchal translucency (NT) thickness on the myocardial performance index (MPI) in fetuses without cardiac anomaly in the first trimester and to determine ... -
High expression of CD8 in the tumor microenvironment is associated with PD-1 expression and patient survival in high-grade serous ovarian cancer
Ölmez, Fatma; Oğlak, Süleyman Cemil; Ölmez, Ömer Fatih; Akbayır, Özgür; Yılmaz, Ercan; Akgöl, Sedat; Konal, Merve; Seyhan, Niyazi Alper; Kinter, Alp Koray (Turkish Society of Obstetrics and Gynecology, 2022)Objective: The current study assesss programmed death-1 (PD-1) receptor expression and CD3, CD4, and CD8 tumor-infiltrating lymphocytes (TILs) in high-grade serous ovarian cancer (HGSOC) and to associate our results with ...